Enhancing responses to cancer immunotherapy
Author:
Affiliation:
1. Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
2. Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Abstract
Publisher
American Association for the Advancement of Science (AAAS)
Subject
Multidisciplinary
Reference10 articles.
1. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
3. Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles
4. Neoantigens in cancer immunotherapy
5. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intra-tumoral T cells in pediatric brain tumors display clonal expansion and effector properties;Nature Cancer;2024-01-16
2. The germline HLA-A02B62 supertype is associated with a PD-L1-positive tumour immune microenvironment and poor prognosis in stage I lung cancer;Heliyon;2023-08
3. Germline mechanisms of immunotherapy toxicities in the era of genome‐wide association studies;Immunological Reviews;2023-07-28
4. Biomarkers and immunotherapy: where are we?;Current Opinion in Oncology;2022-09
5. Pinpointing the tumor-specific T cells via TCR clusters;eLife;2022-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3